Keywords: bioenvision, gets, orphan, status, clofarex, uk, biopharmaceutical

Bioenvision gets orphan status for Clofarex

Article | 12 December 2001

UK biopharmaceutical company Bioenvision and US partner ILEX Oncologyhave been awarded orphan drug status by the European Medicines Evaluation Agency ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Clofarabine

Clolar

Go to drug listing